A carregar...
Initial treatment for patients with chronic myeloid leukemia
The first-line treatment of chronic myeloid leukemia is based on the three currently available tyrosine kinase inhibitors (TKIs), namely imatinib, nilotinib and dasatinib. Nilotinib and dasatinib are more potent, and it is predicted that, in comparison with imatinib, they can reduce the risk of prog...
Na minha lista:
| Publicado no: | Leukemia Suppl |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4851202/ https://ncbi.nlm.nih.gov/pubmed/27175245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leusup.2012.21 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|